[1]
“Comparison of low-dose meglumine antimoniate/ allopurinol combination therapy with full dose meglumine antimoniate alone in the treatment of cutaneous leishmaniasis – A randomized controlled trial”, J Pak Assoc Dermatol, vol. 24, no. 2, pp. 108–114, Dec. 2016, doi: 10.66344/jpad.v24i2.188.